# MIDAZOLAM IN 0.8% SODIUM CHLORIDE
> **NDA215868** · New Drug Application · Sponsor: EXELA PHARMA · Approved 2022-07-20
## Drug
- **FDA Application Number:** NDA215868
- **Application type:** New Drug Application
- **Brand name:** MIDAZOLAM IN 0.8% SODIUM CHLORIDE
- **Generic name:** Midazolam
- **Active ingredients:** MIDAZOLAM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** EXELA PHARMA
- **First approval:** 2022-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215868)
---
*AI Analytics · CC0 1.0*